BioLineRx annual operating margin
2023
2024
2025
BioLineRx Operating Margin Growth & History (BLRX)
BioLineRx's operating margin was −871.78% for fiscal 2025.
View full BioLineRx company overviewBioLineRx annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −871.78% | −801.26 pp |
| 2024 | 2024-12-31 | −70.52% | +964.77 pp |
| 2023 | 2023-12-31 | −1,035.29% | — |
BioLineRx quarterly operating margin
Q2.24
Q2.25
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2025 | 2025-06-30 | −757.57% | — |
| Q2 2024 | 2024-06-30 | −107.05% | — |
BioLineRx operating margin trends
Across the available reported history, BioLineRx's operating margin decreased from −70.52% to −871.78%, a change of −801.26 percentage points. The latest reported quarter, Q2 2025, shows −757.57%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review BioLineRx filings at SEC.gov ↗